Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Exscientia AI Limited
Exscientia AI Limited
Angiex, Inc.
Nanjing Sanhome Pharmaceutical, Co., Ltd.
EtiraRx Australia Pty Ltd
Novita Pharmaceuticals, Inc.
Columbia University
Tvardi Therapeutics, Incorporated
NantBioScience, Inc.
Xencor, Inc.
Pfizer
Second Affiliated Hospital of Guangzhou Medical University
Celldex Therapeutics
Celldex Therapeutics
Xencor, Inc.
Quadriga Biosciences, Inc.
Xencor, Inc.
Novartis
Zhujiang Hospital
University of Chicago
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Santa Maria Biotherapeutics
Curis, Inc.
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
Duke University
University of Chicago
Duke University
Mannkind Corporation
AstraZeneca
Envita Medical Center, Inc.
NS Pharma, Inc.